Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclometasone Dipropionate and Formoterol Inhalation Aerosol in Adult Asthma
CTR20260472Phase 3Active
- Sponsor
- Hefei Licheng Pharmaceutical
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclometasone dipropionate + formoterol in asthma, sponsored by Hefei Licheng Pharmaceutical. Started Feb 2026; status: active.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20260472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260472.